Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 2Pharmaceutical Works POLPHARMA
02 1Aurobindo Pharma Limited
03 1Cipla Ltd.
04 1DARMERICA, LLC
05 1Fagron Inc
06 3Glenmark Life Sciences Limited
07 1Global Calcium Private Limited
08 2Hetero Drugs Limited
09 1Janssen Pharmaceutical Sciences Unlimited Company
10 1MSN Organics Private Limited
11 1Medisca Inc.
12 1Professional Compounding Centers of America
13 1SHODHANA LABORATORIES PRIVATE LIMITED
14 1SciAnda(Changshu) Pharmaceuticals, Ltd.
15 1ScinoPharm Taiwan Ltd.
16 1Siegfried AG
17 1Spectrum Laboratory Products, Inc.
18 1Unichem Laboratories Limited, India
19 1Willow Birch Pharma, Inc
20 1Wuxi Haocheng Kerui Pharmaceutical Technology Co., Ltd.
21 1Zydus Lifesciences Limited
01 3TOPIRAMATE
02 20Topiramate
03 2topiramate
01 12India
02 1Netherlands
03 2Poland
04 1Switzerland
05 2Taiwan
06 5U.S.A
07 1United Kingdom
08 1Blank
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
NDC Package Code : 12658-0410
Start Marketing Date : 1996-12-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
NDC Package Code : 12658-0492
Start Marketing Date : 1996-12-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7532
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (40kg/40kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1206
Start Marketing Date : 2004-09-01
End Marketing Date : 2025-03-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-2443
Start Marketing Date : 2013-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 50379-0007
Start Marketing Date : 2012-06-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0294
Start Marketing Date : 2023-02-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17205-096
Start Marketing Date : 1996-12-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-7827
Start Marketing Date : 2015-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-119
Start Marketing Date : 2024-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate, including repackagers and relabelers. The FDA regulates [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate supplier is an individual or a company that provides [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate active pharmaceutical ingredient (API) or [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate finished formulations upon request. The [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate suppliers may include [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate API manufacturers, exporters, distributors and traders.
click here to find a list of [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate suppliers with NDC on PharmaCompass.
We have 19 companies offering [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0?,?]dodecan-6-yl]methyl sulfamate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
